NYSE:GSK

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc (LON:GSK; NYSE:GSK) is drifting quietly higher on Friday, 28 November 2025, with investors digesting a fresh “Hold” consensus from Wall Street, another round of share buybacks and a still‑busy drug pipeline that has pushed the stock close to

28 November 2025

GSK (GSK) news today — Nov 11, 2025: New AN2 TB collaboration, buyback activity filed, shares test 12‑month high

GSK PLC Share Price: What to Know Before the London Market Opens on 17 November 2025

As London investors get ready for the opening bell on Monday, 17 November 2025, GSK plc (LON: GSK) is entering the week in a strong but finely balanced position: the shares sit close to their 52‑week highs, the company has

16 November 2025

Financial News · GSK PLC · Investing · London Exchange · NYSE:GSK · Stock Market

SPRO Stock Skyrockets on Breakthrough Oral Antibiotic Data

Stock Performance stockanalysis.com stockanalysis.com Spero’s shares have roughly doubled this year, hitting around $2.29 on Oct 20, 2025. The stock has traded in a broad range ($0.51–$3.22 over 52 weeks) stockanalysis.com. Trading volume is light (hundreds of thousands of shares),

21 October 2025

Biotechnology · Investing · Medical News · NASDAQ:SPRO · NYSE:GSK · Pharmaceuticals · Stock Market

European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

Key Facts: Indices Performance European markets closed the first day of the week with small gains. The pan‑European STOXX 600 edged up 0.18% to 555.53 aa.com.tr. Germany’s DAX 40 barely budged (+0.02%) to 23,745.06 aa.com.tr, while Britain’s FTSE 100 added

30 September 2025

Economic Outlook · European Markets · Healthcare · Luxury Goods · NYSE:AZN · NYSE:CCL · NYSE:GSK · Stock Market · Stocks

European Stocks Rally on Pharma Shakeups, Tech Surge – What’s Next?

Market Overview On Monday, Europe’s stock markets built on last week’s Fed-inspired optimism. Investors cheered a mix of corporate news and the prospect of more US rate cuts. Britain’s FTSE 100 climbed roughly 0.5%, putting it near record highs, and

29 September 2025

European Markets · Investment Strategies · NYSE:AZN · NYSE:GSK · Pharmaceuticals · Stock Market · Technology

Wall Street Braces for Shutdown: Stocks Rally as Fed Cuts Loom – Tech & Defense in Focus

Sources: Reuters, CNBC, Bloomberg, company filings reuters.com globenewswire.com reuters.com reuters.com reuters.com reuters.com reuters.com.

29 September 2025

Defense Industry · Economic Policy · Federal Reserve · NYSE:AZN · NYSE:GSK · NYSE:JEF · NYSE:STLA · Stock Market · Technology

Tariffs Fail to Derail European Stock Rally as Markets Bounce Back

Market Recap: Relief Rally Ends a Volatile Week German DAX stock index graph displayed at the Frankfurt Stock Exchange. European markets rebounded off three-week lows heading into the weekend (Sept. 24, 2025) reuters.com reuters.com European stocks staged a broad relief

27 September 2025

European Economy · Financial News · Market Analysis · NYSE:AZN · NYSE:GSK · NYSE:IHG · Stock Market · Trade Tariffs

Inside Altos Labs: Jeff Bezos’s $3 Billion Bet to Reverse Aging

Sources

20 September 2025

Biotechnology · Health Innovation · Longevity · NASDAQ:AMZN · NASDAQ:GOOG · NASDAQ:GOOGL · NYSE:GSK · Scientific Research · Startups

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Key Facts Scientific Breakthroughs & New Research Leading our roundup are several significant scientific and medical breakthroughs. Researchers in New York unveiled a potential “universal” antiviral strategy, reporting compounds that neutralized seven different viruses across multiple families in lab tests

30 August 2025

Biotech · Global News · Health · Medicine · NASDAQ:CYTK · NYSE:GSK · NYSE:SNY · Public Health

Game-Changing Vaccines, Breakthrough Drugs, and a CDC Shakeup: Biotech & Health News Roundup

In-Depth Report COVID-19 Vaccines and U.S. Public Health Upheaval Targeted Fall Boosters, But Access Tightened: U.S. health authorities approved new monovalent COVID-19 vaccines (by Pfizer–BioNTech, Moderna, and Novavax) updated for the 2025–26 season reuters.com. Unlike prior booster rollouts, the FDA

28 August 2025

Biotechnology · CDC · Health · Medicine · NASDAQ:JAZZ · NYSE:GSK · NYSE:LLY · NYSE:NVO · Vaccines

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered

24 August 2025

Biotech · Global Health · Healthcare · Investments · Medical Breakthroughs · NASDAQ:DVAX · NASDAQ:RCKT · NYSE:GSK · NYSE:NVO

NYSE:GSK News 24 August 2025 - 28 November 2025